The extracellular pH (pHe) of tumor tissues is often acidic, which can induce the expression of several proteins. We previously showed that production of matrix metalloproteinase-9 (MMP-9) was induced by culturing cells at acidic pHe (5.4 -6.5). Here we have investigated the signal transduction pathway by which acidic pHe induces MMP-9 expression. We found that acidic pHe (5.9) activated phospholipase D (PLD), and inhibition of PLD activity by 1-butanol and Myr-ARF6 suppressed the acidic pHe-induced MMP-9 expression. Exogenous PLD, but not phosphatidylinositol-specific PLC or PLA 2 , mimicked MMP-9 induction by acidic pHe. Western blot analysis revealed that acidic pHe increased the steady-state levels of phosphorylated extracellular signal-regulated kinases 1/2 and p38 and that the PLD inhibitors suppressed these increases. Using 5-deletion mutant constructs of the MMP-9 promoter, we found that the acidic pHe-responsive region was located at nucleotide ؊670 to ؊531, a region containing the NFB binding site. A mutation into the NFB binding site reduced, but not completely, the acidic pHe-induced MMP-9 promoter activity, and NFB activity was induced by acidic pHe. Pharmacological inhibitors specific for mitogen-activated protein kinase kinase 1/2 (PD098059) and p38 (SB203580) attenuated the acidic pHe-induced NFB activity and MMP-9 expression. These data suggest that PLD, mitogen-activated protein kinases (extracellular signal-regulated kinases 1/2 and p38), and NFB mediate the acidic pHe signaling to induce MMP-9 expression. A transcription factor(s) other than NFB may also be involved in the MMP-9 expression.Proteolytic degradation of extracellular matrix is important for tumor metastasis and angiogenesis. The matrix metalloproteinases (MMPs) 1 constitute a family of extracellular matrixdegrading enzymes. Among these enzymes, MMP-9/gelatinase B plays an important role in tumor invasion and metastasis because of its specificity for type IV collagen. Because the promoter region of the MMP-9 gene contains a TATA box and nuclear factor-B (NFB) and activator protein-1 (AP-1) binding sites, expression of MMP-9 mRNA can be up-regulated by stimuli such as interleukin (IL)-1 and tumor necrosis factor-␣ (1). In addition, MMP-9 expression can be up-regulated by phorbol 12-O-tetradecanoate 13-acetate through phospholipase D (PLD) (2, 3).Mitogen-activated protein kinases (MAPKs) are crucial enzymes in the receptor-mediated signaling cascade. There are three major groups of MAPKs, extracellular signal-regulated kinase (ERK) 1/2, p38, and c-Jun N-terminal kinase (JNK) 1/2. PD98059 and SB203580, which are specific inhibitors of MAPK kinase (MEK) 1/2 and p38, respectively, repress MMP-9 expression and in vitro tumor cell invasion (4, 5). Moreover, the JNK inhibitor SP600125 has been shown to attenuate phorbol 12-O-tetradecanoate 13-acetate-induced MMP-9 expression (6).The extracellular pH (pHe) of solid tumors is acidic due to the presence of anaerobic glucose metabolites such as lactate. For example, the basal pHe of xenograft...